Table of Contents
- Introduction
- What Is Spilanthol?
- What Does "Safe" Actually Mean?
- Hazard, Risk and Exposure: Three Different Concepts
- Natural Does Not Automatically Mean Safe
- What Types of Safety Evidence Exist?
- Why Concentration Matters
- Why Route of Exposure Matters
- Why Formulation Matters
- Spilanthol vs Acmella oleracea Extract
- Why Study Results Need Context
- Conclusion to Part 1
Introduction
Spilanthol is one of the best-known natural compounds found in Acmella oleracea, the plant commonly known as paracress, toothache plant, electric daisy and Buzz Buttons.
Its unusual sensory effect makes it difficult to ignore. Contact with Acmella oleracea, particularly the flower heads, can produce a distinctive tingling, buzzing and mouth-watering sensation.
This biological activity is one reason spilanthol has attracted interest from researchers, cosmetic scientists, food innovators and botanical extract manufacturers.
But it also raises an important question:
How safe is spilanthol?
At first glance, this may seem like a question that should have a simple answer. In toxicology and cosmetic safety science, however, substances are rarely classified meaningfully as simply "safe" or "unsafe" without considering the conditions under which exposure occurs.
A more scientifically useful set of questions would be:
- What substance or extract is being evaluated?
- What concentration is being used?
- How much exposure occurs?
- How frequently does exposure occur?
- Is it applied to skin, consumed or studied in another way?
- How long does the exposure continue?
- Is the ingredient used alone or within a formulation?
- What type of evidence supports the safety assessment?
- Which questions have not yet been adequately studied?
These distinctions matter enormously.
A laboratory experiment exposing isolated cells to a relatively high concentration of spilanthol does not recreate normal cosmetic use. Likewise, the traditional consumption of Acmella oleracea cannot by itself establish the safety of every concentrated extract, every purified preparation or every possible exposure level.
This is where careful interpretation becomes essential.
The purpose of this deep dive is not to declare spilanthol universally safe or unsafe. Instead, it is to examine what current scientific evidence can reasonably tell us, what it cannot tell us, and where uncertainty remains.
That distinction is central to responsible botanical science.
1. What Is Spilanthol?
Spilanthol is a naturally occurring N-alkylamide, a group of specialised compounds produced by certain plants.
Its molecular formula is commonly given as:
C₁₄H₂₃NO
Spilanthol is strongly associated with Acmella oleracea and contributes to the plant's characteristic sensory properties.
When fresh flower material comes into contact with the mouth, the sensation may include:
- tingling;
- buzzing;
- increased salivation;
- a temporary alteration in oral sensation.
These obvious sensory effects demonstrate an important point.
Spilanthol is biologically active.
But biological activity should not be confused with either toxicity or safety.
Many substances interact with biological systems without being inherently dangerous under normal conditions of use. The safety question depends on factors such as dose, exposure, formulation and route of administration.
Spilanthol Is Not the Whole Plant
One of the most important distinctions in this article is the difference between:
spilanthol
and
Acmella oleracea.
They are not interchangeable terms.
Acmella oleracea is a botanical species containing a complex mixture of naturally occurring constituents.
Spilanthol is one compound within that chemical mixture.
The plant may also contain other alkamides and numerous additional phytochemicals.
Therefore:
Evidence about Acmella oleracea is not automatically evidence about isolated spilanthol.
The reverse is also true.
A study involving purified spilanthol cannot automatically predict how a complex Acmella oleracea extract will behave.
This distinction becomes especially important when interpreting safety studies.
2. What Does "Safe" Actually Mean?
In everyday conversation, we often describe something as either safe or dangerous.
Safety science is more precise.
A substance may present little concern under one set of conditions but become problematic under another.
Consider something as familiar as caffeine.
The effects of a small amount in a beverage are very different from exposure to a highly concentrated quantity.
The chemical has not changed. The dose and exposure conditions have.
The same principle applies when evaluating botanical compounds such as spilanthol.
Safety Is Context Dependent
A meaningful safety assessment should consider several variables together:
Identity
What exactly is being evaluated?
Is it:
- purified spilanthol;
- a standardised Acmella oleracea extract;
- dried flower material;
- fresh plant material;
- a finished cosmetic formulation?
These are chemically different materials.
Concentration
How much spilanthol is present?
An extract containing a small percentage of spilanthol is not equivalent to purified or highly enriched spilanthol.
Exposure
How much material actually reaches the person?
Concentration alone does not describe total exposure.
Frequency
Is the exposure:
- once;
- occasionally;
- daily;
- several times per day?
Repeated exposure can raise different questions from single exposure.
Duration
Was the ingredient used for minutes, days, months or years?
Long-term safety questions require different evidence from short-term compatibility testing.
Route
Was the substance:
- applied to intact skin;
- applied to damaged skin;
- swallowed;
- inhaled;
- injected;
- tested directly on cultured cells?
These exposure routes cannot be treated as equivalent.
3. Hazard, Risk and Exposure: Three Different Concepts
One of the most useful concepts in safety science is the distinction between hazard and risk.
They are related, but they do not mean the same thing.
What Is a Hazard?
A hazard is the inherent potential of something to cause harm under particular circumstances.
For example, a substance might have the potential to:
- irritate tissue;
- affect cells at sufficiently high concentrations;
- cause sensitisation in susceptible individuals.
Identifying a hazard does not automatically tell us whether normal use presents a meaningful risk.
What Is Exposure?
Exposure describes the contact between a substance and a biological system.
Important exposure variables include:
- concentration;
- amount;
- duration;
- frequency;
- route.
Without exposure, a hazard may never translate into a meaningful practical risk.
What Is Risk?
Risk considers both the potential hazard and the actual conditions of exposure.
A simplified way of thinking about the relationship is:
Hazard + Exposure Context = Risk
This is not a formal mathematical equation. It is a useful conceptual model.
The distinction becomes especially important when reading scientific studies.
Why This Matters for Spilanthol
Imagine that researchers expose cultured cells directly to spilanthol at a particular concentration and observe a biological response.
That study may provide valuable information about:
- cellular mechanisms;
- concentration-dependent effects;
- potential biological activity.
But it does not automatically demonstrate that a cosmetic containing an Acmella oleracea extract presents the same effect when applied to intact human skin.
The exposure conditions are fundamentally different.
This is why study design matters so much.
4. Natural Does Not Automatically Mean Safe
Acmella oleracea is a plant, and spilanthol is naturally occurring.
That does not provide automatic proof of safety.
The idea that "natural equals safe" is scientifically unreliable.
Nature contains compounds ranging from essential nutrients to extremely potent toxins.
Botanical origin tells us where a substance comes from, not whether every concentration and exposure scenario is safe.
Natural Origin Still Matters
This does not mean natural origin is irrelevant.
Traditional use, dietary exposure and historical botanical use can provide valuable information, particularly when combined with modern analytical and toxicological research.
However, such information must be interpreted in context.
For example, eating a small quantity of fresh Acmella oleracea is not equivalent to exposure to highly concentrated isolated spilanthol.
Extraction changes concentration.
Purification can change it even further.
5. What Types of Safety Evidence Exist?
Not all scientific evidence answers the same question.
Understanding the different evidence types helps prevent overinterpretation.
Analytical Chemistry
Before safety can be evaluated properly, researchers need to know what substance they are studying.
Analytical techniques may be used to determine:
- chemical identity;
- purity;
- spilanthol concentration;
- composition of an extract;
- presence of other compounds.
Techniques such as high-performance liquid chromatography (HPLC) are particularly useful for quantifying spilanthol.
Analytical chemistry provides strong information about what is present.
It does not, by itself, establish safety.
This distinction connects directly with our separate Madabuzz Knowledge Hub guide on how spilanthol is measured.
Laboratory and In Vitro Studies
In vitro research examines biological processes outside a complete living organism.
Researchers may study:
- cultured cells;
- isolated tissues;
- biochemical pathways.
These experiments can provide valuable information about how spilanthol interacts with biological systems.
They are particularly useful for:
- identifying mechanisms;
- exploring concentration-response relationships;
- generating hypotheses;
- identifying areas requiring further investigation.
However, they have an important limitation.
A cell culture is not a human being.
Direct exposure of isolated cells can be very different from applying a cosmetic formulation to the surface of intact skin.
Preclinical Research
Preclinical research may include animal models or reconstructed biological systems.
These studies can provide information that cannot easily be obtained from simple cell cultures.
They may help researchers explore:
- biological mechanisms;
- tissue responses;
- absorption;
- metabolism;
- dose relationships.
However, translating findings from preclinical models to humans requires caution.
Animal biology and human biology overlap in many ways, but they are not identical.
Human Studies
Human research is particularly valuable when assessing real-world applications.
Depending on study design, researchers may investigate:
- skin compatibility;
- cosmetic performance;
- sensory response;
- tolerance;
- instrumental skin measurements.
Human studies are often more directly relevant to consumer use than cell or animal experiments.
However, even human studies have limitations.
A study involving a small group of healthy adults over several weeks cannot automatically answer questions about:
- years of repeated exposure;
- every skin type;
- children;
- pregnancy;
- damaged skin;
- unusually high concentrations.
The details of the study population and design therefore matter.
Traditional Use
Acmella oleracea has a history of culinary and traditional use in different regions.
Historical use can provide useful context.
However:
traditional use is evidence of exposure, not automatic proof of safety under every modern application.
A traditional food preparation may differ dramatically from:
- a concentrated botanical extract;
- purified spilanthol;
- a leave-on cosmetic;
- a novel delivery system.
Traditional knowledge and modern safety science can complement each other, but they answer different questions.
6. Why Concentration Matters
Perhaps no variable is more important to interpreting spilanthol research than concentration.
A botanical extract containing spilanthol is not equivalent to pure spilanthol.
This seems obvious, but the distinction is frequently lost when scientific findings are simplified online.
More Spilanthol Means More Exposure at the Same Dose of Extract
Imagine two extracts.
Extract A: relatively low spilanthol concentration
Extract B: substantially higher spilanthol concentration
If the same amount of each extract is used in otherwise comparable conditions, Extract B delivers more spilanthol.
That does not automatically make Extract B better or worse.
It simply changes the exposure.
Safety assessment must take that difference into account.
This is one reason why the claim that "more spilanthol always means a better extract" is scientifically too simplistic.
7. Why Route of Exposure Matters
The same substance can behave differently depending on how it enters or contacts the body.
This concept is known as the route of exposure.
For spilanthol, researchers may encounter very different exposure scenarios.
Topical Exposure
Cosmetic products are generally designed for application to the skin.
The skin provides a sophisticated biological barrier.
Factors influencing topical exposure include:
- formulation;
- concentration;
- application area;
- frequency;
- skin condition;
- contact time.
Oral Exposure
Consuming Acmella oleracea creates a very different exposure scenario.
The substance interacts with:
- oral tissues;
- saliva;
- the digestive system;
- metabolic processes.
Oral evidence therefore cannot automatically be transferred to cosmetic exposure.
Direct Cellular Exposure
In laboratory studies, cells may be exposed directly to spilanthol.
This removes many of the biological barriers present during real-world use.
Such experiments can be scientifically valuable, but their results require careful interpretation.
8. Why Formulation Matters
A cosmetic ingredient does not usually exist in isolation.
It becomes part of a formulation containing other ingredients.
These may include:
- water;
- oils;
- emulsifiers;
- humectants;
- antioxidants;
- preservatives;
- surfactants;
- thickeners.
The formulation can influence how an ingredient behaves.
The Finished Product Is the Relevant Consumer Exposure
Suppose a manufacturer purchases an Acmella oleracea extract containing a defined amount of spilanthol.
That extract might then represent only a fraction of the finished cosmetic formula.
The consumer is therefore not necessarily exposed to the same spilanthol concentration reported on the raw ingredient's Certificate of Analysis.
This distinction is essential.
For example:
spilanthol concentration in extract ≠ spilanthol concentration in finished product
The actual finished-product concentration depends on how much extract is used.
9. Spilanthol vs Acmella oleracea Extract
This distinction deserves particular attention because it is one of the easiest sources of confusion.
An Acmella oleracea extract is a mixture.
Depending on the extraction process, it may contain:
- spilanthol;
- other alkamides;
- lipophilic plant constituents;
- other extracted phytochemicals;
- solvent or carrier components.
Purified spilanthol is chemically much narrower.
The two materials should therefore not automatically share the same safety profile.
Extraction Method Matters
Different extraction methods can produce extracts with different chemical compositions.
Variables include:
- plant part;
- solvent;
- extraction temperature;
- extraction time;
- particle size;
- raw material quality;
- concentration steps.
An extract from flower heads may differ considerably from one made from mixed aerial material.
Likewise, an oil-based extract may not have the same chemical profile as an ethanol-derived extract.
This is why ingredient identity and analytical characterisation matter before safety evidence can be interpreted properly.
10. Why Study Results Need Context
Scientific papers often produce findings that appear simple when reduced to a headline.
Reality is usually more complicated.
Imagine reading:
"Spilanthol affected cells in laboratory testing."
That statement alone tells us very little.
We would need to know:
- What cells?
- What concentration?
- For how long?
- Was pure spilanthol used?
- Was an extract used?
- What solvent was used?
- What biological endpoint was measured?
- Was there a dose-response relationship?
- Were the concentrations relevant to realistic human exposure?
Without these details, it is easy to draw conclusions that the study itself does not support.
A Positive Result Is Not Automatically a Safety Concern
Another important point is that a measurable biological effect is not automatically harmful.
Researchers deliberately measure biological responses.
A change observed in a laboratory experiment might represent:
- normal cellular signalling;
- a pharmacological effect;
- an adaptive response;
- irritation;
- toxicity;
- another biological mechanism.
Interpretation depends on the endpoint and study design.
This is why phrases such as "biologically active" and "toxic" should never be treated as synonyms.
A Negative Result Does Not Answer Every Safety Question
The opposite problem also occurs.
Suppose a study finds no adverse effect under specific experimental conditions.
That provides useful evidence for those conditions.
It does not prove that no adverse effect could occur:
- at a higher concentration;
- after longer exposure;
- through another exposure route;
- in a sensitive population;
- in a different formulation.
Scientific conclusions should remain proportional to the evidence.
What We Can Already Say With Confidence
Even before examining individual safety studies in Part 2, several principles are clear.
Spilanthol is:
- a naturally occurring alkamide associated with Acmella oleracea;
- biologically active;
- present at different concentrations depending on plant material and extraction;
- studied using analytical, laboratory, preclinical and human research approaches.
At the same time, no responsible safety assessment should rely on botanical origin alone.
The relevant question is not simply:
"Is spilanthol safe?"
It is:
"Is this specific material, at this concentration and level of exposure, sufficiently supported for this particular use?"
That is a much stronger scientific question.
Why This Matters for Cosmetic Ingredients
For cosmetic manufacturers, safety evaluation should extend beyond reading a single scientific paper or looking at the spilanthol percentage on a Certificate of Analysis.
A broader quality picture may include:
- botanical identity;
- plant part;
- extraction method;
- spilanthol concentration;
- ingredient specifications;
- microbiological quality;
- contaminants where relevant;
- recommended use level;
- finished formulation;
- intended application;
- exposure conditions.
A Certificate of Analysis can confirm important quality parameters, but it does not replace a complete safety assessment.
Likewise, a high spilanthol percentage should not automatically be presented as evidence that an extract is superior.
Potency, quality and safety are related concepts, but they are not the same thing.
Conclusion to Part 1
Evaluating spilanthol safety requires more than deciding whether a natural compound is "safe" or "unsafe." Modern safety science examines the identity of the substance, its concentration, route of exposure, frequency and duration of use, formulation, and the population being exposed. These factors determine whether findings from a particular experiment are relevant to real-world use.
It is equally important to distinguish purified spilanthol from Acmella oleracea extracts and finished cosmetic formulations. Evidence generated with one cannot automatically be applied to the others. Laboratory studies can reveal mechanisms, preclinical models can expand biological understanding, human studies can provide more directly relevant information, and traditional use can contribute useful historical context. Each evidence type has strengths and limitations.
This evidence hierarchy prevents two opposite mistakes. The first is assuming that a natural history of use proves universal safety. The second is treating any biological effect observed under laboratory conditions as evidence of danger to consumers. Both conclusions ignore exposure and context.
In Part 2, we will move from these fundamental principles to the research itself, examining what laboratory, preclinical and human evidence can currently tell us about spilanthol, topical cosmetic use and skin compatibility, while carefully separating established findings from conclusions that the available evidence does not yet justify.
Part 2: What Current Research Actually Shows
Table of Contents
- From Safety Theory to Scientific Evidence
- What Laboratory Studies Can Tell Us
- What Preclinical Research Adds
- What Human Evidence Can Tell Us
- Spilanthol and Topical Cosmetic Use
- Skin Compatibility, Irritation and Sensitisation
- Why Extract Safety Is Not the Same as Pure Spilanthol Safety
- Dose, Concentration and Exposure
- What Traditional Use Can Contribute
- How to Interpret Conflicting Research
- What the Evidence Supports So Far
- Conclusion to Part 2
13. From Safety Theory to Scientific Evidence
In Part 1, we established an important principle: asking whether spilanthol is simply "safe" or "unsafe" is not enough.
Safety depends on context.
Researchers need to consider:
- chemical identity;
- concentration;
- dose;
- route of exposure;
- frequency;
- duration;
- formulation;
- individual characteristics.
The next question is therefore more specific:
What does existing research actually tell us about spilanthol safety?
Spilanthol has been investigated in laboratory experiments, preclinical models and studies involving topical applications. Acmella oleracea itself also has a history of traditional and culinary use.
Together, these sources provide useful information.
However, the evidence is not equally strong for every possible use or exposure scenario.
That distinction is crucial.
Scientific evidence can support conclusions only within the boundaries of what has actually been studied.
14. What Laboratory Studies Can Tell Us
A significant amount of early research into botanical compounds begins in the laboratory.
These studies are often described as in vitro research.
"In vitro" literally means "in glass", although modern experiments may involve sophisticated cell culture systems, isolated tissues and biochemical assays.
Researchers can use these systems to investigate how spilanthol interacts with biological processes under carefully controlled conditions.
Why In Vitro Research Is Valuable
Laboratory research allows scientists to control variables that would be difficult to isolate in humans.
Researchers may investigate:
- cellular responses;
- biochemical pathways;
- membrane interactions;
- concentration-dependent effects;
- potential mechanisms of action.
This can help establish whether a compound is biologically active and identify questions for further research.
For spilanthol, such studies form an important part of the scientific evidence base.
But they also have limitations.
Cells in a Dish Are Not Human Skin
This point cannot be emphasised enough.
A cultured cell may be exposed directly to a defined concentration of spilanthol.
Human skin is much more complicated.
The outer layer of the skin, particularly the stratum corneum, acts as an important barrier between the external environment and living tissue.
A cosmetic ingredient applied to intact skin must interact with this barrier before reaching deeper tissues.
In contrast, cells growing in laboratory culture may have no comparable protective layer.
Therefore, a concentration producing an effect in vitro cannot automatically be assumed to produce the same effect when incorporated into a cosmetic product.
Concentration Can Change the Result
Laboratory studies frequently test several concentrations.
This is important because biological responses can be concentration dependent.
A compound may produce little measurable response at one concentration and a much stronger response at another.
That does not mean the compound suddenly changes identity.
It means exposure has changed.
When interpreting an in vitro spilanthol study, one of the first questions should therefore be:
What concentration was actually tested?
The second should be:
Is that concentration relevant to realistic human exposure?
Without those answers, translating the finding into a consumer safety conclusion is difficult.
15. What Preclinical Research Adds
Preclinical research can provide information beyond simple cell culture experiments.
Depending on the study, researchers may use:
- animal models;
- isolated tissues;
- reconstructed skin models;
- other experimental biological systems.
These models can help researchers investigate how a compound behaves in more complex biological environments.
What Preclinical Studies Can Explore
Preclinical research may help investigate:
- local biological responses;
- absorption;
- distribution;
- metabolism;
- concentration-response relationships;
- mechanisms that cannot be studied adequately in isolated cells.
This information can be valuable when deciding whether further research is justified.
But Translation to Humans Is Not Automatic
Animal and experimental models are designed to approximate aspects of biology.
They do not perfectly reproduce human exposure.
Differences may exist in:
- skin structure;
- metabolism;
- body size;
- exposure conditions;
- physiology.
A biological effect observed in an animal model should therefore be treated as evidence about that model, not immediate proof of an identical effect in people.
This principle works in both directions.
An absence of adverse findings in a preclinical experiment also does not establish universal human safety.
16. What Human Evidence Can Tell Us
When the question concerns cosmetic use, human evidence can be especially informative because it brings the research closer to real-world exposure.
Human cosmetic studies may examine:
- skin compatibility;
- visible skin responses;
- participant-reported sensations;
- instrumental measurements;
- tolerability during repeated use.
These studies can provide useful information about a particular formulation under defined conditions.
However, even human studies need careful interpretation.
A Finished Cosmetic Is Not Pure Spilanthol
Suppose a study evaluates a cream containing an Acmella oleracea extract.
The results relate primarily to:
that formulation, at that ingredient concentration, under those study conditions.
They do not automatically establish the safety of:
- pure spilanthol;
- every Acmella oleracea extract;
- a formulation containing ten times as much extract;
- oral exposure;
- long-term use over many years.
This distinction is one of the most important lessons when reviewing cosmetic research.
Study Population Matters
Who participated in the research?
A study conducted with healthy adult volunteers may provide useful information for healthy adults.
It may provide much less information about:
- children;
- people with severely compromised skin barriers;
- people with specific allergies;
- pregnant individuals;
- other populations not included in the study.
Researchers should therefore avoid extending conclusions far beyond the population actually investigated.
17. Spilanthol and Topical Cosmetic Use
Spilanthol and Acmella oleracea extracts have attracted particular attention in cosmetic science.
This raises a practical safety question:
What happens when an ingredient containing spilanthol is incorporated into a topical formulation?
The answer depends on much more than the presence of spilanthol alone.
The Skin Barrier Matters
Human skin is not a passive sheet.
Its outer layers help regulate the movement of substances between the body and the environment.
Topical exposure depends on several interacting variables, including:
- molecular properties;
- ingredient concentration;
- vehicle;
- application area;
- contact time;
- condition of the skin.
Formulation therefore becomes part of the exposure question.
Penetration Is Not the Same as Toxicity
Research into botanical compounds sometimes examines whether molecules can penetrate or permeate biological barriers.
Such findings are frequently misunderstood.
The fact that a molecule can interact with or move through skin does not automatically mean that it is harmful.
Likewise, poor penetration does not automatically mean a substance is safe.
These are separate scientific questions.
Safety assessment must consider both exposure and biological effect.
18. Skin Compatibility, Irritation and Sensitisation
Two concepts that are often confused are irritation and sensitisation.
They describe different biological processes.
What Is Skin Irritation?
Irritation is generally a local response to exposure.
Depending on the substance and conditions, signs may include:
- redness;
- discomfort;
- burning;
- dryness;
- other local reactions.
The likelihood and severity of irritation can depend on concentration and exposure duration.
What Is Sensitisation?
Sensitisation involves the immune system.
After sensitisation has developed, later exposure to the relevant substance may trigger an allergic response in a susceptible person.
Irritation and sensitisation therefore require different forms of assessment.
A material that does not produce obvious irritation in a short-term experiment cannot automatically be assumed to have no sensitisation potential.
Why Finished-Product Testing Matters
A raw botanical extract may behave differently once incorporated into a finished cosmetic.
The final formulation determines the consumer's actual exposure.
Responsible cosmetic development therefore considers not only the raw ingredient but also the safety and compatibility of the finished product under its intended conditions of use.
19. Why Extract Safety Is Not the Same as Pure Spilanthol Safety
This distinction deserves its own chapter because it is central to understanding the research.
Consider three materials:
Material A
Fresh Acmella oleracea flower head.
Material B
A botanical extract standardised to a defined spilanthol concentration.
Material C
Highly purified spilanthol.
All three contain spilanthol.
But chemically, they are not the same material.
A Botanical Extract Is a Mixture
An extract can contain numerous compounds derived from the plant.
Its composition depends on factors including:
- plant part;
- harvest stage;
- extraction solvent;
- extraction temperature;
- extraction time;
- purification;
- concentration.
The extraction process determines which compounds are transferred from the plant into the extract.
Purification Changes Exposure
As spilanthol becomes increasingly concentrated or purified, a smaller amount of material may deliver a larger quantity of the compound.
This changes the exposure calculation.
It also means that historical experience with the whole plant cannot automatically be transferred to highly concentrated spilanthol.
The Reverse Is Also True
Findings involving purified spilanthol should not automatically be attributed to every Acmella oleracea extract.
A botanical extract may contain a much lower concentration.
The finished cosmetic may contain an even lower concentration again.
This is why accurate analytical data are essential.
Without knowing the concentration of spilanthol, meaningful comparisons between products and studies become much more difficult.
20. Dose, Concentration and Exposure
Safety discussions often focus heavily on concentration.
Concentration is important, but it is not the whole story.
Concentration
Concentration describes how much of a substance is present within a material.
For example, a Certificate of Analysis might report the measured spilanthol concentration of an extract.
That is useful information.
But it does not tell us how much extract will be used in a finished product.
Use Level
The cosmetic manufacturer decides how much extract is incorporated into the formulation.
If an extract contains a known percentage of spilanthol and is then used at a defined percentage in a cosmetic, the theoretical spilanthol concentration in the finished product can be estimated.
This distinction is essential.
An extract containing a relatively high percentage of spilanthol does not mean the finished cosmetic contains that same percentage.
Amount Applied
Exposure also depends on how much finished product is used.
A tiny amount applied to a small area differs from repeated application over a large body surface.
Frequency
A product applied once per week creates a different exposure pattern from one applied several times each day.
Duration
Short-term exposure and long-term repeated exposure are different safety questions.
A study lasting days or weeks cannot necessarily answer what happens after years of regular use.
21. What Traditional Use Can Contribute
Acmella oleracea has a history of culinary and traditional use.
This information should neither be dismissed nor overstated.
Traditional use can provide valuable evidence that people have experienced particular forms of exposure.
However, it has limitations as formal safety evidence.
What Traditional Use Can Tell Us
A history of use may help researchers understand:
- how the plant has been prepared;
- which plant parts have been used;
- typical routes of exposure;
- known sensory characteristics;
- culturally established applications.
This can provide useful context for modern research.
What Traditional Use Cannot Establish
Traditional use cannot automatically establish the safety of:
- isolated spilanthol;
- highly concentrated extracts;
- novel extraction methods;
- every cosmetic formulation;
- unusually high exposure levels.
Traditional exposure and modern concentrated ingredients may differ substantially.
22. How to Interpret Conflicting Research
Scientific literature does not always produce identical results.
One study may observe an effect while another does not.
This does not necessarily mean that one study is wrong.
The experiments may simply be different.
Check the Material Tested
Was the study conducted using:
- pure spilanthol;
- an Acmella oleracea extract;
- another Acmella species;
- a finished formulation?
Botanical identity matters.
Check the Concentration
Two studies using dramatically different concentrations should not be expected to produce identical results.
Check the Exposure Time
A short experiment and a long experiment answer different questions.
Check the Biological Model
Results from:
- isolated enzymes;
- cultured cells;
- reconstructed skin;
- animals;
- humans
should not be treated as equivalent evidence.
Check the Endpoint
What exactly did researchers measure?
Possibilities include:
- cell viability;
- biochemical signalling;
- skin redness;
- sensory response;
- absorption;
- another biological marker.
Different endpoints can produce different conclusions.
23. Evidence Strength Is Not Just About Study Count
A common mistake in online health and cosmetic content is counting studies.
For example:
"Ten studies show X, while only three show Y."
This approach can be misleading.
Ten weak experiments do not necessarily outweigh one well-designed study that directly addresses the relevant question.
Evidence should instead be assessed according to:
- study design;
- methodological quality;
- relevance;
- sample size;
- exposure conditions;
- reproducibility;
- consistency with other evidence.
This is particularly important for specialised botanical ingredients where the research literature may still be developing.
What the Evidence Supports So Far
The available research allows several cautious conclusions.
First, spilanthol is a biologically active natural compound. Its characteristic sensory properties and laboratory findings make that clear.
Second, research involving Acmella oleracea and spilanthol spans several evidence levels, including analytical chemistry, laboratory experiments, preclinical research and human applications.
Third, safety findings are strongly dependent on concentration and exposure conditions.
Fourth, evidence concerning a botanical extract should not automatically be applied to purified spilanthol, and evidence involving pure spilanthol should not automatically be applied to every botanical extract.
Fifth, cosmetic safety must ultimately consider the finished formulation and its intended use, not simply the concentration reported for the raw ingredient.
What We Should Not Conclude Yet
Current evidence should not be stretched to support claims such as:
"Spilanthol is completely safe at any concentration."
That conclusion would ignore dose and exposure.
Likewise, it would be inappropriate to conclude:
"Spilanthol is dangerous because laboratory studies demonstrate biological effects."
Biological activity alone does not establish harmful real-world exposure.
Other overly broad conclusions should also be avoided, including:
- natural means universally safe;
- traditional use proves the safety of purified spilanthol;
- one cosmetic study proves long-term safety;
- one cell study proves human toxicity;
- a higher spilanthol concentration means a safer or better extract.
The evidence does not justify such generalisations.
Why Quality Control Is Part of the Safety Picture
Safety research assumes that the material being evaluated is what the manufacturer says it is.
That makes quality control extremely important.
For an Acmella oleracea ingredient, relevant quality considerations may include:
- correct botanical identification;
- defined plant part;
- traceable sourcing;
- controlled extraction;
- analytical measurement of spilanthol;
- microbiological quality;
- relevant contaminant controls;
- batch documentation.
A well-characterised botanical ingredient provides a much stronger foundation for safety assessment than an extract of uncertain identity or composition.
The Role of the Certificate of Analysis
A Certificate of Analysis, commonly abbreviated to CoA, can provide important batch-specific information.
Depending on the ingredient and specification, it may document parameters such as:
- botanical identity;
- spilanthol concentration;
- analytical method;
- moisture;
- microbiological results;
- selected contaminants;
- batch identification.
However, a CoA answers primarily a quality and specification question.
It does not independently prove that an ingredient or finished cosmetic is safe under every condition of use.
Quality control and safety assessment complement each other, but they are not interchangeable.
A Better Way to Ask the Safety Question
Instead of asking:
"Is spilanthol safe?"
a cosmetic scientist might ask:
"What evidence supports the use of this characterised spilanthol-containing ingredient at this concentration in this formulation, for this intended route, frequency and duration of exposure?"
The second question is longer.
It is also far more scientifically meaningful.
This approach reflects how modern safety assessment works.
It moves the discussion away from simplistic labels and towards measurable variables.
Conclusion to Part 2
Current research provides meaningful information about spilanthol, but the strength of that evidence depends heavily on the question being asked. Laboratory studies help identify biological activity and mechanisms. Preclinical models provide additional information about biological responses under more complex conditions. Human cosmetic studies can move closer to real-world use, particularly when the actual formulation and exposure conditions are clearly defined.
None of these evidence types should be interpreted in isolation. Direct exposure of cultured cells to spilanthol does not reproduce normal application of a formulated cosmetic to intact human skin. Similarly, traditional consumption of Acmella oleracea does not automatically establish the safety of purified spilanthol or highly concentrated extracts.
Concentration, formulation, route of exposure, amount applied, frequency and duration all influence the safety question. The distinction between pure spilanthol, an Acmella oleracea extract and a finished cosmetic product is therefore essential.
The available evidence supports careful, context-dependent evaluation rather than sweeping conclusions. It provides useful pieces of the safety picture, but important uncertainties remain.
In Part 3, we will examine those uncertainties in detail, including long-term exposure, highly concentrated spilanthol, sensitive populations, individual variability and the limitations of existing studies. We will also explore how manufacturers can evaluate spilanthol-containing ingredients responsibly, explain what quality documentation can and cannot establish, answer the most important safety FAQs, and reach a final evidence-based conclusion about what current science can genuinely tell us.
